SPECIES DISTRIBUTION OF CANDIDA SPP. IN PATIENTS WITH VULVOVAGINAL CANDIDIASIS

Thị Xuân Tâm Huỳnh, Thảo Phúc Lê

Main Article Content

Abstract

Objective: Determine the distribution of Candida albicans and Candida non-albicans species causing vulvovaginal candidiasis in women attending Ho Chi Minh City Hospital of Dermatology and Venereology. Materials and Methods: A cross-sectional descriptive study. Vaginal discharge samples were collected from 70 women with confirmed vulvovaginal candidiasis at Ho Chi Minh City Hospital of Dermatology and Venereology from 03/2025 to 07/2025. Direct microscopic examination with 10% KOH and culture on Sabouraud dextrose agar and CHROMagar™ Candida were performed to isolate and identify the Candida species. Results: Candida albicans was predominant (83.6%), while Candida non-albicans species included C. glabrata (9.6%), C. tropicalis (4.1%), and C. parapsilosis (2.7%). The majority of patients were aged 18–29 years (65.7%), followed by 30–39 years (18.6%), whereas the ≥50 age group accounted for only 2.9%. Most patients lived in urban areas (85.7%), used tap water as their main source of domestic water (74.3%), and had a high educational level (75.7% with a university degree). In terms of occupation, office staff, students, and freelance workers comprised the largest groups, accounting for 34.3%, 20% and 24.3%, respectively. Conclusion: Candida albicans remains the predominant causative agent of vulvovaginal candidiasis compared with Candida non-albicans species. Culture, species identification, and antifungal susceptibility surveillance are essential to guide appropriate therapeutic choices and to improve the management of vulvovaginal candidiasis in women.

Article Details

References

Workowski KA. Sexually transmitted infections treatment guidelines, 2021. MMWR Recommendations and Reports. 2021;70.
2. Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. Published online 2015.
3. Makanjuola O, Bongomin F, Fayemiwo SA. An update on the roles of non-albicans Candida species in vulvovaginitis. Journal of Fungi. 2018;4(4):121.
4. Liu X, Fan S, Peng Y, Zhang H. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012. Journal de mycologie medicale. 2014;24(2):106-111.
5. Anh DN, Hung DN, Tien TV, et al. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam. BMC infectious diseases. 2021;21(1):523.
6. Châu NTM, Anh TNP. Xác định loài vi nấm và đánh giá sự đề kháng với một số thuốc kháng nấm của các loài nấm Candida sp. gây viêm âm đạo phân lập được ở Bệnh viện Trường Đại học Y Dược Huế. Tạp chí Phụ sản. 2016;13(4):44-47.
7. Dovo EE, Sorgho A, Ouedraogo E, et al. Vulvovaginal Candidiasis: Profile of Antifungal Susceptibility Test of Candida Strains to Antifungal Drugs from 2018 to 2022, Ouagadougou, Burkina Faso. Advances in Microbiology. 2025;15(1):58-69.